Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingavirin in children aged 6 months to 2 years with influenza and acute respiratory infections
NCT05269290Phase 3Completed
- Sponsor
- Valenta Pharm
- Start
- Sep 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Ingavirin in influenza, Acute Respiratory Infection (ARI), sponsored by Valenta Pharm. Started Sep 2021; status: completed.
02
Drugs
Ingavirin
03
Conditions
influenzaAcute Respiratory Infection (ARI)
Beyond the preview
Go deeper on NCT05269290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05269290.